Bosch Health Campus Logo Bosch Health Campus Logo
Home
News

IKP celebrated 50th anniversary

From Bench to Bedside

-Personalized Medicine as Key to Targeted Therapy-

September 7, 2023 | Maritim Hotel Stuttgart

IKP | September 2023

Impressions

More Impressions in our 

Late 1973, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP), Stuttgart, opened its doors and started operating with a number of staff of 4.
Originating from a generous donation by Dr. Margarete Fischer-Bosch, the eldest daughter of Robert Bosch, the institute has been growing over the past 50 years to an internationally highly recognized institution with major translational research activities in the field of pharmacogenomics and personalized medicine.

Mensch
AdobeStock

Welcome

14:00   Prof. Mark Dominik Alscher | Bosch Health Campus
14:05Dr. Christof Bosch | Representative of the Bosch Family
14:10Dr. Bernhard Straub | Robert Bosch Foundation
14:15Dr. Ute Leidig | State Secret., Ministry for Social Affairs, Health & Integration, Baden-Wuerttemberg
14:20Prof. Samuel Wagner | Vice Dean for Digit. & Young Scientists, Med. Faculty of the Univ. Tuebingen


Moderation | Dr. Astrid Viciano, Medical Journalist

Opening Symposium

14:25   Prof. Matthias Schwab | Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology


Lectures

14:30  Prof. Dan Mark Roden | Vanderbilt University, Medical Center, Nashville, USA
 Tools to probe variable drug actions: from pluripotent stem cells to electronic health records
14:55Prof. Henk-Jan Guchelaar | Leiden University Medical Center, Netherlands
 Pharmacogenomics: the time for implementation is now
15:20Prof. Georg Schett | Vice President Research, FAU, Med. Faculty, Intern. Med.III, Erlangen, Germany
 Car-T cell therapy in autoimmune disease
15:45Coffee break
16:15Prof. V. Craig Jordan | University of Texas, MD Anderson Cancer Center, Houston, USA
 Tamoxifen from failed contraceptive to the first targeted therapy to treat breast cancer and an on-site into Selective Estrogen Receptor Modulators in  women’s health
16:40Prof. Juliane Walz | University Hospital Tuebingen, Germany
 Peptide-based immunotherapy – bench to bedside development
17:05Prof. Heyo Kroemer | CEO Charité, University Medicine Berlin, Germany
 The Future of Health